3 Dividend Stocks Ill Never Sell - The Motley Fool
| BIOEN Stock | TRY 16.88 0.22 1.29% |
Under 61% of Biotrend Cevre's investor base is looking to short. The analysis of current outlook of investing in Biotrend Cevre ve suggests that many traders are alarmed regarding Biotrend Cevre's prospects. Biotrend Cevre's investing sentiment shows overall attitude of investors towards Biotrend Cevre ve.
Biotrend |
3 Dividend Stocks Ill Never Sell The Motley Fool
Read at news.google.com
 |
Biotrend Cevre Fundamental Analysis
We analyze Biotrend Cevre's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotrend Cevre using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotrend Cevre based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Biotrend Cevre is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Biotrend Cevre ve Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotrend Cevre stock to make a market-neutral strategy. Peer analysis of Biotrend Cevre could also be used in its relative valuation, which is a method of valuing Biotrend Cevre by comparing valuation metrics with similar companies.
Peers
Biotrend Cevre Related Equities
| NATEN | Naturel Yenilenebilir | 0.70 | ||||
| METUR | Metemtur Yatrm | 0.53 | ||||
| AKSEN | Aksa Enerji | 0.44 | ||||
| PAMEL | Pamel Yenilenebilir | 0.50 | ||||
| GWIND | Galata Wind | 1.34 | ||||
| AYDEM | Aydem Yenilenebilir | 1.55 |
Complementary Tools for Biotrend Stock analysis
When running Biotrend Cevre's price analysis, check to measure Biotrend Cevre's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotrend Cevre is operating at the current time. Most of Biotrend Cevre's value examination focuses on studying past and present price action to predict the probability of Biotrend Cevre's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotrend Cevre's price. Additionally, you may evaluate how the addition of Biotrend Cevre to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |